文献速递眼底病与葡萄膜炎神经眼科

超越高血糖:代谢综合征中视网膜神经退行性变的证据

Beyond Hyperglycemia, Evidence for Retinal Neurodegeneration in Metabolic Syndrome.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本研究比较29例代谢综合征患者与36名年龄匹配健康对照的视网膜OCT分层厚度,发现代谢综合征组在部分ETDRS亚区中神经节细胞层、内丛状层和光感受器层更薄,提示代谢综合征固有因素可能独立于高血糖产生神经退行性影响。

要点

  • 代谢综合征组神经节细胞层在2/9个ETDRS亚区较对照更薄(52.4±5.1 μm vs 54.8±3.8 μm,P=0.030)。
  • 内丛状层在3/9个亚区更薄(39.8±4.4 μm vs 43.0±3.5 μm,P=0.003),光感受器层在7/9个亚区更薄(79.4±2.9 μm vs 81.1±2.9 μm,P=0.009)。
  • 神经纤维层、内核层、外丛状层和外核层厚度无显著差异。

核心结论

  • 代谢综合征患者OCT分层分析显示内层视网膜和光感受器层更薄,提示代谢综合征固有因素(如胰岛素抵抗和脂肪组织来源炎症)可能独立于糖尿病高血糖水平产生神经退行性效应。

研究设计与样本

  • 横断面研究,纳入29例代谢综合征患者和36名年龄、性别匹配的健康瘦对照,行频域OCT视网膜分层分析。
  • 排除糖尿病、未控制高血压、视网膜病变、高度近视或远视及后节手术者。

主要发现

  • 代谢综合征组神经节细胞层在2/9个ETDRS亚区较对照更薄(52.4±5.1 μm vs 54.8±3.8 μm,P=0.030)。
  • 内丛状层在3/9个亚区更薄(39.8±4.4 μm vs 43.0±3.5 μm,P=0.003)。
  • 光感受器层在7/9个亚区更薄(79.4±2.9 μm vs 81.1±2.9 μm,P=0.009)。
  • 神经纤维层、内核层、外丛状层和外核层厚度无显著差异。

临床怎么用

  • 作者认为,对于超重的2型糖尿病合并代谢综合征患者,除血糖控制措施外,也可能建议减重以预防视网膜神经退行性变的发生。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated the retinal effects of systemic metabolic changes clustered under the umbrella of metabolic syndrome (MetS) in comparison with age-matched healthy subjects. METHODS: Spectral-domain optical coherence tomography (OCT) retinal segmentation analysis of 29 patients with MetS and 36 control subjects was performed. Patients with diabetes mellitus (DM), uncontrolled hypertension, retinopathy, high myopia or hyperopia, and posterior segment surgery, were excluded from analysis. The control group (CG) was selected from age- and sex-matched healthy lean subjects. Mean thickness values of individual retinal layers in nine macular early treatment of diabetic retinopathy study (ETDRS) subfields were determined. RESULTS: The MetS group had a significantly thinner ganglion cell layer in two (MetS, 52.4 ± 5.1 μm; CG, 54.8 ± 3.8 μm; P = 0.030), thinner inner plexiform layer in three (MetS, 39.8 ± 4.4 μm; CG, 43.0 ± 3.5 μm; P = 0.003), thinner photoreceptor layer in seven (MetS, 79.4 ± 2.9 μm; CG, 81.1 ± 2.9 μm; P = 0.009) of nine ETDRS subfields. No difference was found in nerve fiber, inner nuclear, outer plexiform, and outer nuclear layers. CONCLUSIONS: The patients with MetS had thinner inner retinal layers and photoreceptor layer in OCT segmentation analysis, which suggests that inherent factors of MetS, such as insulin resistance and adipose tissue-derived inflammation, might have a neurodegenerative effect independent of the hyperglycemic levels associated with DM. Therefore, beyond glycemic control measures, weight reduction also might be advised to overweight patients with type 2 DM and MetS to prevent the occurrence of retinal neurodegeneration.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Karaca C, Karaca Z. Beyond Hyperglycemia, Evidence for Retinal Neurodegeneration in Metabolic Syndrome. Invest Ophthalmol Vis Sci. 2018. PMID: 29625459. doi:10.1167/iovs.17-23376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。